AzTrials
AzTrials

COPDNCT01303913

Predicting Oxygen Desaturation in Chronic Obstructive Pulmonary Disease (COPD) Patients

An observational study of COPD, run by Villa Pineta Hospital at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Oxygen desaturation (SO2 < 88-90%) during walking is a common clinical feature of Chronic Obstructive Pulmonary Disease (COPD) patients. By a predicted analysis our study is aimed to evaluate anthropometric and functional characteristics of COPD patients correlated with oxygen desaturation during Six-minute walking… Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
COPD
How many people
400 participants
Where
1 siteItaly
Study dates
Jun 2010to Feb 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: COPD patients

Who may be able to join

  • COPD patients
  • Ability to perform 6MWT
  • Normal oxygen saturation at rest and at the begin of 6MWT

Who cannot join

  • No-COPD patients
  • Chronic Respiratory Failure patients in Long-term oxygen therapy (LTOT)
  • Any co-morbidities

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Villa Pineta Hospital

    Pavullo nel Frignano, Modena, 41026

Other trials in Italy

About this study

Official title: Composite Analysis on Factors That Predict Oxygen Desaturation During Walking in COPD

Oxygen desaturation (SO2 < 88-90%) during walking is a common clinical feature of Chronic Obstructive Pulmonary Disease (COPD) patients. By a predicted analysis our study is aimed to evaluate anthropometric and functional characteristics of COPD patients correlated with oxygen desaturation during Six-minute walking test (6MWT).

Conditions
COPD
Keywords
COPD, Oxygen desaturation, Walking test
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01303913
Study groupRoleWhat they receive
Walking desaturation groupCOPD patients that at the end of 6MWT have SO2 nadir <88-90%
Walking No-desaturation groupCOPD patients that at the end of 6MWT have SO2 nadir >88-90%

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen saturation nadir (SO2 nadir)

    Measured by change in percentage (%)

    Measured: Measured at the end of 6MWT

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2011 (estimated)
  2. Study startJun 2010
  3. Study completionFeb 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01303913
Sponsor's protocol ID
VP03-2010
Status last verified
Feb 2011
First submitted
24 Feb 2011
Last updated
28 Feb 2011
Results posted
No
Data monitoring committee
No

Publications

  • Crisafulli E, Iattoni A, Venturelli E, Siscaro G, Beneventi C, Cesario A, Clini EM. Predicting walking-induced oxygen desaturations in COPD patients: a statistical model. Respir Care. 2013 Sep;58(9):1495-503. doi: 10.4187/respcare.02321. Epub 2013 Jan 29.

    PubMed 23362168

Questions about this trial

What is this clinical trial studying?

An observational study of COPD, run by Villa Pineta Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen saturation nadir (SO2 nadir) (time frame: Measured at the end of 6MWT). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01303913, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in